Development of lung and muscle protein factories to deliver therapeutic monoclonal antibodies

Development of lung and muscle protein factories to deliver therapeutic monoclonal antibodies

Recombinant therapeutic proteins, of which monoclonal antibodies (mAbs) represent the largest market, are used to treat diseases including cancer, blood and immune disorders. The cost and complexity of large-scale production and purification of mAbs translates to high cost of therapy. We hypothesise...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Antepowicz, A, Tan, A, Pringle, A, Hyde, S, Gill, D
Formaat:	Conference item
Gepubliceerd in:	Mary Ann Liebert Inc 2016

Gelijkaardige items

Development of lung and muscle factories to deliver therapeutic monoclonal antibodies
door: Antepowicz, A
Gepubliceerd in: (2018)

431. Lung antibody factory for passive immunisation against influenza
door: Tan, T, et al.
Gepubliceerd in: (2016)

Lentiviral-mediated expression of monoclonal antibodies in the lung to protect against influenza
door: Du, Y, et al.
Gepubliceerd in: (2020)

Antibody gene transfer for prophylaxis of respiratory syncytial virus (RSV) infection
door: Antepowicz, A, et al.
Gepubliceerd in: (2018)

The lung as a factory to produce secreted intrapulmonary and circulatory proteins
door: Paul-Smith, M, et al.
Gepubliceerd in: (2017)

Development of monoclonal antibody therapeutics for alzheimer's disease
door: Masatoshi Takeda
Gepubliceerd in: (2022-01-01)

The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins
door: Paul-Smith, M, et al.
Gepubliceerd in: (2018)

Monoclonal Antibodies as Neurological Therapeutics
door: Panagiotis Gklinos, et al.
Gepubliceerd in: (2021-01-01)

Therapeutic monoclonal antibody for Sporotrichosis
door: Sandro eAlmeida
Gepubliceerd in: (2012-11-01)

The development of gene therapy for diseases of the lung.
door: Gill, DR, et al.
Gepubliceerd in: (2004)

Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections
door: Leonardo F. Ormundo, et al.
Gepubliceerd in: (2023-10-01)

Advances and challenges in therapeutic monoclonal antibodies drug development
door: Mariana Lopes dos Santos, et al.
Gepubliceerd in: (2018-11-01)

Host cell protein profiling of commercial therapeutic protein drugs as a benchmark for monoclonal antibody-based therapeutic protein development
door: Rosalynn Molden, et al.
Gepubliceerd in: (2021-01-01)

Glycoengineering of AAV-delivered monoclonal antibodies yields increased ADCC activity
door: James M. Termini, et al.
Gepubliceerd in: (2021-03-01)

Monoclonal antibodies for the therapeutic induction of tolerance.
door: Waldmann, H, et al.
Gepubliceerd in: (1993)

Therapeutic potential of monovalent monoclonal antibodies.
door: Cobbold, S, et al.
Gepubliceerd in: (1984)

The pharmacology and therapeutic applications of monoclonal antibodies
door: María Sofía Castelli, et al.
Gepubliceerd in: (2019-12-01)

Monoclonal antibodies as potent therapeutics in dentistry.
door: Pratichi Tripathi, et al.
Gepubliceerd in: (2019-05-01)

Development and validation of an analytical procedure for the determination of residual protein A in active substances of therapeutic monoclonal antibodies
door: E. V. Nozdrina, et al.
Gepubliceerd in: (2024-03-01)

Therapeutic Monoclonal Antibodies against Cancer: Present and Future
door: Marisa Delgado, et al.
Gepubliceerd in: (2023-12-01)

Development of an anti-Pseudomonas aeruginosa therapeutic monoclonal antibody WVDC-5244
door: Alexander M. Horspool, et al.
Gepubliceerd in: (2023-04-01)

Corrigendum: Therapeutic potential of monovalent monoclonal antibodies
door: Cobbold, S, et al.
Gepubliceerd in: (1984)

Therapeutic Uses of Monoclonal Antibodies for COVID-19
door: Tarun Kumar Suvvari
Gepubliceerd in: (2020-01-01)

Development and Characterization of Monoclonal Antibodies for the Detection of Fish Protein
door: Yi-Tien Chen, et al.
Gepubliceerd in: (2021-10-01)

Intramuscular rAAV2/8 mediated expression of etanercept in mice with collagen-induced arthritis
door: Habib, O, et al.
Gepubliceerd in: (2019)

Expression profile of optimised SIV vector in the mouse lung at early timepoints post-delivery
door: Pringle, I, et al.
Gepubliceerd in: (2018)

DEVELOPMENT AND PROPERTIES OF NEUTRALIZING MONOCLONAL ANTIBODIES FOR FUSION PROTEIN OF RESPIRATORY SYNCYTIAL VIRUS
door: A. A. Kushch, et al.
Gepubliceerd in: (2019-04-01)

Therapeutic potential of monoclonal antibodies to the leucocyte common antigen.
door: Bindon, C, et al.
Gepubliceerd in: (1985)

Identification and characterisation of candidate monoclonal antibody Ebolavirus therapeutics
door: Donnellan, FR
Gepubliceerd in: (2021)

Monoclonal antibodies and aptamers: The future therapeutics for Alzheimer's disease
door: Alvaro Barrera-Ocampo
Gepubliceerd in: (2024-07-01)

Therapeutic monoclonal antibodies with a focus on hereditary angioedema
door: Bruce L. Zuraw, et al.
Gepubliceerd in: (2023-01-01)

Monoclonal Antibodies Targeting Ion Channels and Their Therapeutic Potential
door: Aurélien Haustrate, et al.
Gepubliceerd in: (2019-06-01)

The history and potential future of monoclonal antibody therapeutics development and manufacturing in four eras
door: Brian Kelley
Gepubliceerd in: (2024-12-01)

Developing Monoclonal Antibodies for Immunohistochemistry
door: Jacqueline Cordell
Gepubliceerd in: (2022-01-01)

Binding of omeprazole to protein targets identified by monoclonal antibodies
door: Naw May Pearl Cartee, et al.
Gepubliceerd in: (2020-01-01)

Monoclonal antibodies in inflammatory disease of the muscle and peripheral nervous system
door: J.J. Poza Aldea
Gepubliceerd in: (2012-01-01)

Monoclonal antibody techniques. 50 years of development
door: Yulia S. Massino, et al.
Gepubliceerd in: (2024-07-01)

Impact of Urea on Monoclonal Antibodies: Multiple Destabilization and Aggregation Effects for Therapeutic Immunoglobulin G Proteins
door: Ji Young Yang, et al.
Gepubliceerd in: (2024-01-01)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
door: Antepowicz, A, et al.
Gepubliceerd in: (2021)

Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins
door: Liming Liu
Gepubliceerd in: (2017-04-01)